Sivik Global Healthcare’s Humana HUM Stock Holding History

Sivik Global Healthcare’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.47M	Hold	20,000	–	–	2.63%	17
2026 Q1	$3.47M	Buy	20,000 +5,000	+33%	+$1.02M	2.63%	17
2025 Q4	$3.84M	Sell	15,000 -10,000	-40%	-$2.62M	1.11%	33
2025 Q3	$6.5M	Sell	25,000 -2,000	-7%	-$526K	1.89%	17
2025 Q2	$6.6M	Buy	27,000 +4,000	+17%	+$997K	1.8%	23
2025 Q1	$6.09M	Buy	23,000 +3,000	+15%	+$811K	3.29%	15
2024 Q4	$5.07M	Buy	20,000 +10,000	+100%	+$2.68M	2.67%	18
2024 Q3	$3.17M	Buy	10,000 +2,500	+33%	+$890K	1.34%	30
2024 Q2	$2.8M	Sell	7,500 -12,500	-63%	-$4.22M	1.01%	36
2024 Q1	$6.93M	Buy	20,000 +5,000	+33%	+$1.9M	1.63%	14
2023 Q4	$6.87M	Sell	15,000 -2,500	-14%	-$1.23M	2.87%	12
2023 Q3	$8.51M	Hold	17,500	–	–	4.3%	3
2023 Q2	$7.83M	Sell	17,500 -5,000	-22%	-$2.52M	1.83%	12
2023 Q1	$10.9M	Buy	22,500 +9,500	+73%	+$4.7M	4.7%	2
2022 Q4	$6.66M	Buy	13,000 +2,500	+24%	+$1.31M	3.13%	11
2022 Q3	$5.09M	Sell	10,500 -5,000	-32%	-$2.43M	2.83%	19
2022 Q2	$7.25M	Sell	15,500 -2,500	-14%	-$1.11M	4.12%	3
2022 Q1	$7.83M	Buy	18,000 +500	+3%	+$209K	3.23%	5
2021 Q4	$8.12M	Buy	17,500 +5,000	+40%	+$2.21M	3.48%	6
2021 Q3	$4.86M	Sell	12,500 -12,500	-50%	-$5.31M	1.16%	34
2021 Q2	$11.1M	Buy	25,000 +5,000	+25%	+$2.18M	2.16%	3
2021 Q1	$8.38M	Buy	20,000 +2,500	+14%	+$998K	3.06%	10
2020 Q4	$7.18M	Sell	17,500 -2,500	-13%	-$1.04M	2.93%	13
2020 Q3	$8.28M	Sell	20,000 -47,500	-70%	-$19.1M	3.56%	5
2020 Q2	$11.9M	Buy	67,500 +17,500	+35%	+$6.55M	3.95%	2
2020 Q1	$6.92M	Buy	50,000 +22,500	+82%	+$7.59M	2.73%	18
2019 Q4	$10.1M	Sell	27,500 -1,500	-5%	-$476K	3.74%	1
2019 Q3	$7.41M	Sell	29,000 -3,500	-11%	-$981K	3.74%	3
2019 Q2	$8.62M	Buy	32,500 +2,500	+8%	+$634K	2.08%	2
2019 Q1	$7.98M	Buy	30,000 +10,000	+50%	+$2.88M	2.94%	6
2018 Q4	$5.73M	Sell	20,000 -5,300	-21%	-$1.68M	3.09%	12
2018 Q3	$8.56M	Buy	25,300 +300	+1%	+$97.5K	3.06%	4
2018 Q2	$7.44M	Sell	25,000 -5,000	-17%	-$1.46M	2.86%	5
2018 Q1	$8.06M	Buy	30,000 +5,000	+20%	+$1.35M	3.76%	2
2017 Q4	$6.2M	Sell	25,000 -10,000	-29%	-$2.47M	2.3%	15
2017 Q3	$8.53M	Hold	35,000	–	–	2.9%	3
2017 Q2	$8.42M	Hold	35,000	–	–	3.08%	4
2017 Q1	$7.21M	Sell	35,000 -3,382	-9%	-$699K	3.36%	4
2016 Q4	$7.83M	Sell	38,382 -5,000	-12%	-$954K	3.74%	2
2016 Q3	$7.67M	Buy	43,382 +23,382	+117%	+$4.06M	3.87%	3
2016 Q2	$3.6M	Sell	20,000 -15,000	-43%	-$2.66M	1.79%	27
2016 Q1	$6.4M	Buy	35,000 +15,000	+75%	+$2.6M	2.83%	8
2015 Q4	$3.57M	Sell	20,000 -30,000	-60%	-$5.26M	1.7%	25
2015 Q3	$8.95M	Sell	50,000 -19,700	-28%	-$3.64M	4.34%	3
2015 Q2	$13.3M	Buy	69,700 +14,700	+27%	+$2.73M	4.63%	1
2015 Q1	$9.79M	Buy	55,000 +20,300	+59%	+$3.21M	3.33%	1
2014 Q4	$4.98M	Buy	34,700 +4,700	+16%	+$642K	2.02%	18
2014 Q3	$3.91M	Buy	30,000 +15,000	+100%	+$1.91M	1.78%	22
2014 Q2	$1.92M	Sell	15,000 -9,170	-38%	-$1.09M	0.97%	45
2014 Q1	$2.72M	Sell	24,170 -10,830	-31%	-$1.13M	1.7%	25
2013 Q4	$3.61M	Buy	+35,000	New	+$3.43M	2.57%	8

Other funds holding HUM

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Westwind Capital Las Cruces, New Mexico $422M AUM 17.03% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Sivik Global Healthcare's HUM Position: Q2 2026 in Review

Sivik Global Healthcare held its Humana (HUM) position steady in Q2 2026 at 20,000 shares worth $3.47M. The position accounts for 2.63% of the portfolio, ranked #17.

Sivik Global Healthcare first reported a position in HUM in Q4 2013 and has held it in 51 quarters since. The position peaked at $13.3M in Q2 2015. 215 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

Sivik Global Healthcare held 20,000 shares of Humana worth $3.47M as of Q2 2026.
Sivik Global Healthcare left its Humana share count unchanged in Q2 2026.
Humana made up 2.63% of Sivik Global Healthcare's portfolio in Q2 2026, its #17 holding.
Sivik Global Healthcare first reported a position in Humana in Q4 2013 and has held it in 51 quarters since.
Sivik Global Healthcare's Humana position peaked at $13.3M in Q2 2015.
215 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.